Documentos de Académico
Documentos de Profesional
Documentos de Cultura
tirotoxicosis
Jhoel Sebastian Salas Gomez
Medicina interna
Contenidos
1 2 3 4
Objetivos Definiciones Epidemiología Fisiopatología
5 6 7 8
Manifestaciones Diagnóstico y Anotaciones Conclusiones
clínicas tratamiento relevantes
1
Objetivos
Objetivos
Englobar los
Clasificar los Conocer
mecanismos
tipos y formas diagnósticos
patogénicos del
de hipertiroidismo diferenciales
hipertiroidismo
Mensaje
2
1
Definiciones
Definiciones y conceptos
TSH
T4 T3
fT4 fT4
Definiciones y conceptos
Hipertiroidismo subclínico
TSH
fT4
3
1
Epidemiología
Prevalencia mundial de hipertiroidismo e hipotiroidismo
Taylor, P., Albrecht, D., Scholz, A. et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol 14, 301–316 (2018)
Global iodine nutrition status in 2021
Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers [Internet]. 2022 [cited 2023 Mar
5];8(1):30. Available from: https://www.nature.com/articles/s41572-022-00357-7
4
1
Fisiopatología
Pathogenesis of Graves’ hyperthyroidism
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., … Kahaly, G.
J. (2020). Graves’ disease. Nature Reviews Disease Primers, 6(1). doi:10.1038/s41572-
020-0184-y
Davies, T. F., Andersen, S.,
Latif, R., Nagayama, Y.,
Barbesino, G., Brito, M., …
Kahaly, G. J. (2020). Graves’
disease. Nature Reviews
Disease Primers, 6(1).
doi:10.1038/s41572-020-
0184-y
Signalling cascade by TSHR autoantibodies
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., … Kahaly, G. J. (2020). Graves’ disease. Nature Reviews Disease
Primers, 6(1). doi:10.1038/s41572-020-0184-y
Alteraciones genéticas en las neoplasias malignas foliculares tiroideas
Kumar, V., & Abbas, A. K. (2021). Robbins y Cotran. Patología estructural y funcional. Elsevier Health
Sciences.
Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis,
diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol
[Internet]. 2023 [citado el 6 de marzo de 2023];0(0). Disponible en:
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00005-0/fulltext
Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis.
Lancet Diabetes Endocrinol [Internet]. 2023 [citado el 6 de marzo de 2023];0(0). Disponible en:
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00005-0/fulltext
Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis.
Lancet Diabetes Endocrinol [Internet]. 2023 [citado el 6 de marzo de 2023];0(0). Disponible en:
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00005-0/fulltext
Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis.
Lancet Diabetes Endocrinol [Internet]. 2023 [citado el 6 de marzo de 2023];0(0). Disponible en:
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00005-0/fulltext
Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis.
Lancet Diabetes Endocrinol [Internet]. 2023 [citado el 6 de marzo de 2023];0(0). Disponible en:
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00005-0/fulltext
Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis.
Lancet Diabetes Endocrinol [Internet]. 2023 [citado el 6 de marzo de 2023];0(0). Disponible en:
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00005-0/fulltext
5
1
Manifestaciones clínicas
Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management,
complications, and prognosis. Lancet Diabetes Endocrinol [Internet]. 2023 [citado el 6 de marzo de 2023];0(0).
Disponible en: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00005-0/fulltext
Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management,
complications, and prognosis. Lancet Diabetes Endocrinol [Internet]. 2023 [citado el 6 de marzo de 2023];0(0).
Disponible en: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00005-0/fulltext
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., … Kahaly, G. J. (2020). Graves’ disease. Nature Reviews Disease
Primers, 6(1). doi:10.1038/s41572-020-0184-y
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., … Kahaly, G. J. (2020). Graves’ disease. Nature Reviews Disease
Primers, 6(1). doi:10.1038/s41572-020-0184-y
6
1
Diagnóstico y tratamiento
MARCADOR
CONFIABLE DE DETERMINACION
GOLD STANDARD
FUNCIÓN ETIOLOGICA
TIROIDEA
Clínica
Pruebas bioquímicas
TSH
de función tiroidea Laboratorio
Imagen
Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers [Internet]. 2022 [cited 2023 Mar 5];8(1):30. Available from: https://www.nature.com/articles/s41572-
022-00357-7
Al inicio del manejo:
Seguimiento mensual
Iodo radioactivo
Despues de manejo:
3-6 meses
BB: β-blockers
CCB: calcium channel blockers
GD: Graves’ disease
TMNG: toxic nodular goitre
TED: thyroid eye disease
CI: contraindication
King R, Ajj RA. Treatment Modalities in Thyroid Dysfunction. Thyroid and Parathyroid Diseases - New Insights into Some Old and Some New Issues [Internet]. 2012 Mar 7; Available
from: http://dx.doi.org/10.5772/38536
AIT: amiodarone induced thyrotoxicosis
GD: Graves’ disease
PTU: propylthiouracil
NG: nasogastric
TFT’s: thyroid function tests
ICU: intensive care unit.
King R, Ajj RA. Treatment Modalities in Thyroid Dysfunction. Thyroid and Parathyroid Diseases - New Insights
into Some Old and Some New Issues [Internet]. 2012 Mar 7; Available from: http://dx.doi.org/10.5772/38536
Davies, T. F., Andersen, S.,
Latif, R., Nagayama, Y.,
Barbesino, G., Brito, M., …
Kahaly, G. J. (2020). Graves’
disease. Nature Reviews
Disease Primers, 6(1).
doi:10.1038/s41572-020-
0184-y
Wiersinga WM, Poppe KG, Effraimidis G.
Hyperthyroidism: aetiology, pathogenesis,
diagnosis, management, complications, and
prognosis. Lancet Diabetes Endocrinol [Internet].
2023 [citado el 6 de marzo de 2023];0(0).
Disponible en:
https://www.thelancet.com/journals/landia/article/P
IIS2213-8587(23)00005-0/fulltext
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., … Kahaly, G. J. (2020). Graves’ disease. Nature Reviews Disease
Primers, 6(1). doi:10.1038/s41572-020-0184-y
Management of patients with Graves’ orbitopathy
Anotaciones relevantes
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., … Kahaly, G. J. (2020). Graves’ disease. Nature Reviews Disease Primers, 6(1). doi:10.1038/s41572-020-0184-y
Wiersinga WM, Poppe KG,
Effraimidis G. Hyperthyroidism:
aetiology, pathogenesis,
diagnosis, management,
complications, and prognosis.
Lancet Diabetes Endocrinol
[Internet]. 2023 [citado el 6 de
marzo de 2023];0(0). Disponible
en:
https://www.thelancet.com/journ
als/landia/article/PIIS2213-8587
(23)00005-0/fulltext
Bocio
8
1
Conclusiones
Conclusiones
6. King R, Ajj RA. Treatment Modalities in Thyroid Dysfunction. Thyroid and Parathyroid Diseases - New Insights
into Some Old and Some New Issues [Internet]. 2012 Mar 7; Available from: http://dx.doi.org/10.5772/38536